Sonoma Pharmaceuticals Q3 revenue rises 22%
Overview
Healthcare product maker's fiscal Q3 revenue rose 22% yr/yr
Net loss and EBITDAS loss decreased for fiscal Q3 compared to last year
Company expanded distribution channels and strengthened leadership
Outlook
Sonoma Pharmaceuticals did not provide specific financial guidance for future quarters or fiscal year
Result Drivers
U.S. SALES GROWTH - Revenue in the U.S. surged 98% due to increased sales of over-the-counter products and distributor expansion
EUROPEAN DEMAND - European revenues rose 24% driven by increased demand for products
LATIN AMERICA DECLINE - Latin America revenues fell 38% due to timing of customer orders
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue |
| $4.30 mln |
|
Q3 Gross Profit |
| $1.60 mln |
|
Q3 Operating Expenses |
| $2.30 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "strong buy"
The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 408.6% above its February 9 closing price of $2.91
Press Release: ID:nACSCchpCa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
After $20B Debt Sale, Google’s Rare 100-Year Bond Sparks Scrutiny: Has AI Drained the Tech Giant’s Coffers?
TradingKey - According to a Financial Times report, Google parent Alphabet (GOOG)(GOOGL) is planning to issue bonds denominated in British pounds and Swiss francs, which may include the first 100-year GBP bond of this century.
Netflix After the Warner Deal: What Investors Should Know
TradingKey - For quite some time now, Netflix (NFLX) has been regarded as the premier subscription-based streaming service in the world, with a well-established history of growth through creative use of pricing power, developing hit programming, and relying very little on outside sources for licensi
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
